Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Matet de Leon opened up on what it's like to have bipolar disorder during her guesting on Mikee Quintos's show, "Lutong Bahay ...

Zurzuvae, the first pill approved by the FDA to treat postpartum depression, is helping women at Allegheny Health Network and ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

People treated with lithium for mood disorders had an increased risk of developing stage 3 or higher chronic kidney disease ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Medication for depression, anxiety ... The increase in diagnoses of psychiatric conditions in children---bipolar in particular---has led to an increase in the amount of children who take ...

Balance Treatment Center offers a program designed to meet the needs of clients struggling with issues including depression, anxiety, bipolar disorder, psychosis, PTSD, substance abuse ...

is a safe and effective treatment for both manic and depressive symptoms. ECT is often used to treat severe forms of depression or mania in bipolar I disorder when medicines may not be effective ...

It is primarily used to treat schizophrenia in adults but was recently approved by the FDA for the treatment of bipolar depression when taken as a once-daily pill. Cariprazine is a similar ...